Skip to main content
logo
Lukas Biomedical Inc. (TPEX:6814)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.00
-0.10 (-0.43%)
Aug 4, 2026, 12:47 PM CST

Lukas Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9781,2981,2501,0801,1621,374
Market Cap Growth
5.66%3.85%15.69%-6.98%-15.47%-22.59%
Enterprise Value
1,0991,3951,2411,1651,2351,596
Last Close Price
23.3531.0029.8529.1931.3841.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.457.236.594.666.298.72
PB Ratio
4.075.413.843.863.554.79
P/TBV Ratio
4.085.413.843.863.554.80

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.127.776.545.036.6810.13

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.650.650.350.450.340.77
Net Debt / Equity Ratio
0.510.510.160.340.220.55
Net Debt / EBITDA Ratio
-1.74-1.74-0.65-3.58-2.81-8.38
Net Debt / FCF Ratio
-1.74-1.74-0.65-6.53-6.91-5.98
Asset Turnover
0.400.400.410.500.370.30
Inventory Turnover
1.951.952.052.482.512.76
Quick Ratio
0.400.401.310.740.930.64
Current Ratio
0.800.802.191.521.870.92
Return on Equity (ROE)
-30.26%-30.26%-31.15%-15.59%-16.30%-17.14%
Return on Assets (ROA)
-11.23%-11.23%-12.55%-5.91%-5.99%-5.10%
Return on Capital Employed (ROCE)
-26.00%-26.00%-22.00%-11.40%-11.50%-10.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.76%-6.60%-7.55%-4.38%-4.31%-3.60%
FCF Yield
-7.12%-5.37%-6.19%-1.33%-0.90%-1.91%
Buyback Yield / Dilution
-5.80%-5.80%-7.34%-0.27%-11.87%-